tiprankstipranks
Trending News
More News >
Restart Life Sciences (NMLSF)
OTHER OTC:NMLSF
US Market
Advertisement

Restart Life Sciences (NMLSF) Income Statement

Compare
30 Followers

Restart Life Sciences Income Statement

Last quarter (Q1 2025), Restart Life Sciences's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q1, Restart Life Sciences's net income was C$-818.75K. See Restart Life Sciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
C$ 0.00C$ 28.35KC$ 0.00C$ 0.00C$ 11.47K
Gross Profit
C$ 0.00C$ 25.41KC$ -3.79KC$ -5.00KC$ 1.73K
Operating Expenses
C$ 658.51KC$ 1.20MC$ 1.94MC$ 2.93MC$ 1.80M
Depreciation and Amortization
C$ 2.31KC$ 2.94KC$ 3.79KC$ 5.00KC$ 6.82K
EBITDA
C$ -656.20KC$ -1.20MC$ -1.84MC$ -2.80MC$ -1.57M
Operating Income
C$ -658.51KC$ -1.20MC$ -1.17MC$ -3.09MC$ 19.67M
Other Income/Expenses
C$ 883.26KC$ -22.12KC$ -624.18KC$ 249.46KC$ -23.43M
Pretax Income
C$ 224.75KC$ -1.22MC$ -2.47MC$ -2.68MC$ -23.25M
Net Income
C$ 224.75KC$ -1.22MC$ -3.76MC$ -2.44MC$ -44.72M
Per Share Metrics
Basic EPS
C$ 0.01C$ -0.01C$ -0.03C$ -0.02C$ -0.87
Diluted EPS
C$ 0.01C$ -0.01C$ -0.03C$ -0.02C$ -0.87
Weighted Average Shares Outstanding
15.29M 146.78M 136.56M 111.10M 51.15M
Weighted Average Shares Outstanding (Diluted)
16.11M 146.76M 136.56M 111.10M 51.15M
Currency in CAD

Restart Life Sciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis